**Author details**

Aizong Shen<sup>1</sup> \*, Rui Qian<sup>2</sup> , Ting Liu<sup>2</sup> , Qingchuan Liu<sup>3</sup> , Bin Liu<sup>1</sup> and Zhangbao Wu<sup>1</sup>

\*Address all correspondence to: aizongshen@163.com

1 Department of Pharmacy, Anhui Provincial Hospital, Hefei, Anhui Province, China

[10] Wang T, Zhen Y, Ma X, Wei B, Wang N. Phospholipid bilayer-coated aluminum nanoparticles as an effective vaccine adjuvant-delivery system. ACS Applied Materials

Vaccines Developed for Cancer Immunotherapy http://dx.doi.org/10.5772/intechopen.80889 61

[11] Wang N, Wang T. Preparation of multifunctional liposomes as a stable vaccine deliveryadjuvant system by procedure of emulsification-lyophilization. Methods in Molecular

[12] Wang N, Zhen Y, Jin Y, Wang X, Li N, Jiang S, et al. Combining different types of multifunctional liposomes loaded with ammonium bicarbonate to fabricate microneedle arrays as a vaginal mucosal vaccine adjuvant-dual delivery system (VADDS). Journal of

[13] Wang N, Wang T, Zhang M, Chen R, Niu R, Deng Y. Mannose derivative and lipid A dually decorated cationic liposomes as an effective cold chain free oral mucosal vaccine adjuvant-delivery system. European Journal of Pharmaceutics and Biopharmaceutics.

[14] Wang T, Zhen Y, Ma X, Wei B, Li S, Wang N. Mannosylated and lipid A-incorporating cationic liposomes constituting microneedle arrays as an effective oral mucosal HBV vaccine applicable in the controlled temperature chain. Colloids and Surfaces B: Bioin-

[15] Sunshine JC, Green JJ. Nanoengineering approaches to the design of artificial antigen-

[16] Fan Y, Kuai R, Xu Y, Ochyl LJ, Irvine DJ, Moon JJ. Immunogenic cell death amplified by co-localized adjuvant delivery for cancer immunotherapy. Nano Letters. 2017;

[17] Stephan MT, Irvine DJ. Enhancing cell therapies from the outside in: Cell surface engi-

[18] Jung S, Unutmaz D, Wong P, Sano G, De los Santos K, Sparwasser T, et al. In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-

[19] Villadangos JA, Schnorrer P. Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo. Nature Reviews Immunology. 2007;**7**(7):543-555

[20] Cresswell P, Ackerman AL, Giodini A, Peaper DR, Wearsch PA. Mechanisms of MHC class I-restricted antigen processing and cross-presentation. Immunological Reviews.

[21] Munz C. Live long and prosper for antigen cross-presentation. Immunity. 2015;

[22] Zehner M, Marschall AL, Bos E, Schloetel JG, Kreer C, Fehrenschild D, et al. The translocon protein Sec61 mediates antigen transport from endosomes in the cytosol for cross-

presentation to CD8(+) T cells. Immunity. 2015;**42**(5):850-863

neering using synthetic nanomaterials. Nano Today. 2011;**6**(3):309-325

& Interfaces. 2015;**7**(12):6391-6396

Controlled Release. 2017;**246**:12-29

Biology. 2016;**1404**:635-649

2014;**88**(1):194-206

**17**(12):7387-7393

2005;**207**:145-157

**43**(6):1028-1030

terfaces. 2015;**126**:520-530

presenting cells. Nanomedicine. 2013;**8**(7):1173-1189

associated antigens. Immunity. 2002;**17**(2):211-220

2 School of Pharmacy, Anhui Medical University, Hefei, China

3 School of Biomedical Engineering, Hefei University of Technology, Hefei, China
